Drug intelligence / Profile preview

Jingling Oral Liquid

Development stage
Phase 4
Lead developer
Liaoning Dongfangren Pharmaceutical
Administration
Oral
01

Overview

Jingling Oral Liquid is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Jiangsu Kanion Pharmaceutical for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children. The formulation is based on traditional principles of nourishing the liver and kidney while calming the mind, and it contains a complex mixture of ingredients including *Rehmannia glutinosa*, *Cornus officinalis*, *Dioscorea opposita*, *Poria cocos*, and mineral components like Dragon's bone and Oyster shell. Clinical trials in China have demonstrated that Jingling Oral Liquid can significantly improve symptoms of inattention, hyperactivity, and impulsivity, often showing comparable efficacy to methylphenidate or atomoxetine with a more favorable safety profile regarding common side effects like appetite suppression and insomnia. It is widely used in Chinese pediatric practice as both a monotherapy and an adjunctive treatment.

Brand names
Jingling Oral Liquid
Other names
Jingling KoufuyeJing Ling Oral Liquid静灵口服液

Beyond the preview

Go deeper on Jingling Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jingling Oral Liquid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call